Hidden heart risks: new screening program targets undiagnosed disease in cameroon

NCT ID NCT06957548

ENROLLING_BY_INVITATION Diagnosis Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will screen 200 adults in urban Cameroon for undiagnosed cardiometabolic disease risk factors like high blood pressure, diabetes, and obesity. Participants will receive a simple health check to find hidden conditions. The goal is to improve early detection and connect people to care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this screening program could help identify many people with hidden heart and metabolic risks, leading to earlier treatment and better health in urban Cameroon.
What could go wrong: This is a screening study, not a treatment trial. It only measures risk factors and does not test any new drug or therapy. The results may not apply to other regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart disorder metabolic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC DISEASE METABOLIC DISEASE

Contacts and locations

Locations

Newbell Protestant Hospital

Douala, Littoral Region, Cameroon

More trials for these conditions

Other studies related to the condition(s) this trial covers.